AUS
NZ
UK
CA
USA
IND
Highlights
- Surgical Science Sweden AB to acquire Intelligent Ultrasound Group plc for £45.2 million in a cash deal.
- Acquisition represents a premium of up to 79.3% over Intelligent Ultrasound’s recent share price.
- Strategic alignment to strengthen medical simulation technologies and expand product offerings globally.
Surgical Science Sweden AB (LSE:0AAU) has announced plans to acquire Intelligent Ultrasound Group plc (LSE:IUG) in a £45.2 million deal aimed at bolstering its position in the global medical simulation market. The acquisition will be executed through a Court-sanctioned Scheme of Arrangement under Part 26 of the Companies Act 2006. Under the terms, Intelligent Ultrasound shareholders will receive 13 pence in cash per share, representing a premium of up to 79.3% based on historical share prices.
Details of the Acquisition
The boards of both companies have reached a mutual agreement for Surgical Science to acquire the entire issued and to-be-issued ordinary share capital of Intelligent Ultrasound. The acquisition price reflects:
- A 16.9% premium to the closing share price of 11.13 pence on December 18, 2024.
- A 31.1% premium over the 12-month volume-weighted average price of 9.91 pence.
- A substantial 79.3% premium compared to the July 2024 price of 7.25 pence, following the announcement of the sale of Intelligent Ultrasound’s Clinical AI Business to GE HealthCare.
The deal includes provisions that allow Surgical Science to reduce the acquisition price if any dividends or distributions are declared by Intelligent Ultrasound before the transaction is finalized.
Strategic Rationale for the Deal
Surgical Science, a leader in medical simulation technology, views Intelligent Ultrasound as a strategic fit to expand its offerings and address growing demand in healthcare education. Intelligent Ultrasound is renowned for its high-quality ultrasound simulation products, used extensively by medical schools, hospitals, and training institutions.
However, as a standalone entity, Intelligent Ultrasound has faced challenges in achieving sustained growth due to its niche focus and limited organizational scale. The acquisition aligns with Surgical Science’s strategy to diversify its product portfolio, enabling better cross-selling opportunities and a stronger competitive position.
“This acquisition represents an opportunity to combine our expertise in medical simulation with Intelligent Ultrasound’s specialization in ultrasound training,” a Surgical Science representative said. “It strengthens our UK footprint with a research and development site while enhancing our ability to meet healthcare training demands globally.”
The move is also expected to benefit Intelligent Ultrasound by leveraging Surgical Science’s extensive marketing resources, distribution networks, and cross-disciplinary product portfolio.
Funding and Next Steps
The acquisition will be funded through Surgical Science’s existing cash reserves, supplemented by a £17 million short-term bridging loan. The transaction will be subject to shareholder approval and regulatory clearances, with further updates expected in the coming months.
